Applying multi‐omics toward tumor microbiome research – Zhang – iMeta – Wiley Online Library

1), including breast cancer [3], colorectal cancer [4, 5], hepatocellular carcinoma [6, 7], pancreatic cancer [8, 9], skin cancer [10], renal cell carcinoma [11], gastric cancer [12], lung cancer [13, 14], prostate cancer [1517], nasopharyngeal carcinomanHighlight:microbes in the same type of tumors have striking similaritiesnHighlight:DNA damage, oncogenic pathway activation, antitumor drug catabolism, and immune system modulationnHighlight:release of genotoxinsnHighlight:inducing inflammation and affecting key intracellular signal pathways that regulate the growth and proliferation of mucosal cellsnHighlight:Gemcitabine, a chemotherapeutic drug commonly used to treat pancreatic ductal adenocarcinoma, can be metabolized to an inactive state by intratumoral bacteria, thereby resulting in cancer drug resistancenHighlight:affecting host immunosurveillancenHighlight:low biomass of intratumoral bacterianHighlight:heterogeneity of the tumor microenvironment (TME)n]]>

About Dr. Nathan Goodyear
About Dr. Nathan Goodyear

Dr. Nathan Goodyear, a medical doctor with years of experience in the field of integrative cancer care, has announced the launch of an online training program. This program, available on his new website, will provide individuals with access to video trainings led by Dr. Goodyear himself, covering a range of topics related to integrative cancer care. These trainings will include information on the latest research and techniques in the field, as well as guidance on how to incorporate these approaches into a patient’s overall cancer treatment plan. With this online program, Dr. Goodyear hopes to make his expertise and knowledge more widely accessible, and help more people understand the benefits of integrative cancer care.


Leave a Comment

Your email address will not be published. Required fields are marked *

Skip to content